查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
避孕器具市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按产品类型、分销渠道、最终用户、地区细分
市场调查报告书
商品编码
1321020

避孕器具市场 - 2017-2027 年全球行业规模、份额、趋势、机会和预测，按产品类型、分销渠道、最终用户、地区细分

Contraceptive Devices Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented By Product Type, By Distribution Channel, By End User, By Region
出版日期: | 出版商: TechSci Research | 英文 112 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

预计到 2027 年，全球避孕器具市场将以惊人的速度增长。人们使用避孕器具来避免怀孕和传染病通过生殖器传播。市场上的避孕药具包括避孕帽、组合药丸、避孕埋植剂、隔膜、阴道环、宫内节育器和避孕套。这些设备是为男性和女性用户设计和使用的。避孕器具充当物理障碍，阻止精子接触子宫。因此，它有助于抑制受精并降低感染风险。性传播疾病流行率的上升和人们对人口过剩控制意识的增强预计将推动避孕器具市场的发展。

性病患病率上升和意识不断增强正在推动市场发展

由于日常生活方式的不同，人们面临着不同的并发症和问题。生活方式涉及饮食、睡眠时间、体力活动以及压力、焦虑和其他问题等心理状况。 STD（性传播疾病）是一个重大的全球健康问题。据世界卫生组织统计，平均每25人中就有1人患有性病，可能是一种性病，也可能是同时感染多种性病，这意味着全球有4%的人口患有性病。在分析了这种情况后，人们对性传播疾病有了更多的认识，并选择了不同的方法来保证自己的安全。因此，预计未来几年对避孕器具的需求将会增加。世界各地的国际机构和政府正在开展不同的宣传活动并分发避孕器具，以阻止性传播疾病的传播并控制人口的快速增长。世界各国政府正在开展单独的活动，例如性传播感染国家战略计划，并向从事该领域工作的非政府组织或组织提供资金和赠款，以控制性传播疾病。这种有利的条件将对避孕器具的增长产生积极影响。

发展中经济体人口的快速增长是人民和政府的重大关切。印度和中国等国家已经建立了政府组织来帮助不同部门采取预防措施并控制问题。随着现代化的发展，人们工作繁忙，并开始采取计划生育来发展事业。据世界卫生组织统计，2019年全球育龄妇女数量为19亿；其中，11亿人需要计划生育。因此，为了控制人口，对避孕器具的需求将会增加。此外，高吸收率、可支配收入的增加以及市场参与者的努力是导致预计一年市场上避孕器具需求增加的因素。

与避孕器具相关的健康问题正在抑制经济增长

每种药物在完成剂量或治疗后都会对消费者产生副作用。与使用避孕装置所涉及的感染风险增加相同，可能导致不孕。预计这些因素将为避孕器具市场的采用造成障碍。除此之外，缺乏社会接受度以及竞争对手之间的竞争可能会对市场的增长产生负面影响。

加大研发投入

避孕器具市场的扩张正在推动新产品的推出以及组织之间的深思熟虑的合作伙伴关係。当前的场景将帮助两个组织利用其能力开发创新产品并增加利润。除此之外，发达国家可支配收入的增加预计将推动市场。

市场细分

全球避孕器具市场根据产品类型、分销渠道和最终用户进行细分。根据产品类型，市场分为避孕套、隔膜、宫颈帽、海绵、阴道环、宫内节育器（IUD）等。根据分销渠道，市场分为医院药店、零售药店、网上药店等。根据最终用户，市场按公司分为男性和女性。

市场参与者

Cooper Surgical, Inc.、辉瑞公司、默克公司、艾伯维公司、梯瓦製药工业有限公司、Ansell Ltd、拜耳公司、梅耶实验室公司、Church & Dwight Co Inc、Reckitt Benckiser Group plc 是运营的主要参与者避孕器具市场。

可用的定制

根据给定的市场数据，TechSci Research 可根据公司的具体需求提供定制服务。该报告可以使用以下自定义选项：

公司信息

  • 其他市场参与者（最多五个）的详细分析和概况分析。

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：COVID-19 对全球避孕器具市场的影响

第 5 章：客户之声

第 6 章：全球避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型（避孕套、隔膜、宫颈帽、海绵、阴道环、宫内节育器 (IUD) 等）
    • 按分销渠道（医院药房、零售药房、网上药房、其他）
    • 按最终用户（男性与女性）
    • 按公司划分 (2021)
    • 按地区
  • 市场地图

第 7 章：北美避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型
    • 按分销渠道
    • 按最终用户
    • 按国家/地区
  • 北美：国家分析
    • 美国
    • 墨西哥
    • 加拿大

第 8 章：欧洲避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型
    • 按分销渠道
    • 按最终用户
    • 按国家/地区
  • 欧洲：国家分析
    • 法国
    • 德国
    • 英国
    • 意大利
    • 西班牙

第 9 章：亚太地区避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型
    • 按分销渠道
    • 按最终用户
    • 按国家/地区
  • 亚太地区：国家分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳大利亚

第 10 章：南美洲避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型
    • 按分销渠道
    • 按最终用户
    • 按国家/地区
  • 南美洲：国家分析
    • 巴西
    • 阿根廷
    • 哥伦比亚

第 11 章：中东和非洲避孕器具市场展望

  • 市场规模及预测
    • 按价值
  • 市场份额及预测
    • 按产品类型
    • 按分销渠道
    • 按最终用户
    • 按国家/地区
  • MEA：国家分析
    • 南非避孕器具
    • 沙特阿拉伯 避孕器具
    • 阿联酋避孕器具
    • 埃及避孕器具
    • 土耳其避孕器具

第 12 章：市场动态

  • 司机
  • 挑战

第 13 章：市场趋势与发展

第14章：竞争格局

  • 库珀外科有限公司
  • 辉瑞公司
  • 默克公司
  • 艾伯维公司
  • 梯瓦製药工业有限公司
  • 安思尔有限公司
  • 拜耳公司
  • 梅耶实验室公司
  • 丘奇与德怀特公司
  • 利洁时集团有限公司

第 15 章：战略建议

简介目录
Product Code: 12871

The global contraceptive devices market is estimated to increase at an impressive rate through 2027. People use contraceptive devices to avoid pregnancy and infectious diseases spread through their genitals. Contraceptives found in the market include caps, combined pills, contraceptive implants, diaphragms, vaginal rings, intrauterine devices, and a condom. These devices are made for and used by both male and female users. Contraceptive devices act as a physical obstacle preventing sperm from contacting a uterus. Thereby, it helps in restraining insemination and reducing the risk of infection. The rising prevalence of STDs and growing awareness of people's overpopulation control is expected to drive the market for contraceptive devices.

Furthermore, an increase in government initiatives, marketing efforts by the market players, and a rise in disposable income are other factors that are expected to appreciably influence the market's progress through 2027. In 2020, The fertility rate in the United States Fertility Rate was 1.78 per person. The above data shows that people are quite serious about family planning and take precautions to avoid pregnancy. Thus, the United States Contraception market is going to experience growth in the projected year due to their awareness and increasing population.

Rising Prevalence of STDs and Growing Awareness is Propelling the Market

People are facing different complications and problems due to variations in their daily lifestyles. Lifestyle involves diet, sleeping hours, physical activities, and psychological conditions like stress, anxiety, and other problems. STDs (sexually transmitted diseases) are a significant global health issue. According to the WHO, on average, 1 out of 25 people face STDs, which may be one STI or multiple infections at the same time, which means 4% of the global population is suffering from STDs. After analyzing the scenario, people are more aware of the STDs and opt for different methods the keep themselves safe. As a result, the demand for contraceptive devices is expected to swell in the forthcoming years. International agencies and governments worldwide are running different awareness campaigns and distributing contraceptive devices to stop STDs from spreading and controlling the rapid boost of the population. Various governments of the world are running separate campaigns, such as STI National Strategic Plan, and providing funds and grants to NGOs or organizations working in this sector to take control over STDs. This favorable condition is going to impact the growth of contraceptive devices positively.

The rapidly growing population of developing economies is a significant concern for the people as well as the government. Countries like India and China have established government organizations to help the different ministry to take preventive measures and control the problem. Due to modernization, people are busy with their work and are adopting family planning for career building. According to WHO, in 2019, there were 1.9 billion women of reproductive age group globally; out of them, 1.1 billion needed family planning. Thus, the demand for contraceptive devices is going to increase for population control. Additionally, the high absorption rate, rise in disposable income, and effort by the market player are the factor that led to increasing demand for contraceptive devices in the market for a projected year.

Health Issue Associated with Contraceptive Devices is Restraining Growth

Every medicine has side effects on the consumer after completing the dose or treatment. Same as the increased risk of infection involved in the use of a contraceptive device which could lead to infertility. These factors are expected to create hurdles in the adoption of the contraceptive devices market. Apart from these, the lack of social acceptance and competition between the rivals to make the alternative can negatively influence the growth of the market.

Increase in Research and Development Investment

Expansion in the contraceptive devices market is driving the launch of new products and deliberate partnerships among the organizations. The current scenarios will help both organizations to use their competencies to develop innovative products and increase profits. Apart from these, rising disposable income around developed countries is expected to propel the market.

Market Segmentation

The global contraceptive devices market is segmented based on product type, distribution channel, and end user. Based on product type, the market is divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, intrauterine devices (IUDs), and others. Based on distribution channels, the market is divided into hospital pharmacies, retail pharmacies, online pharmacies, and others. Based on end users, the market is split into male and female, by company.

Market Players

Cooper Surgical, Inc., Pfizer, Inc, Merck & Co Inc, AbbVie, Inc, Teva Pharmaceutical Industries Limited, Ansell Ltd, Bayer AG, Mayer Laboratories Inc, Church & Dwight Co Inc, Reckitt Benckiser Group plc are the major player operating in the contraceptive devices Market.

Report Scope

In this report, global Contraceptive Devices Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Contraceptive Devices Market, By Product Type:

  • Condoms
  • Diaphragms
  • Cervical Caps Sponges
  • Vaginal Rings
  • Intra Uterine Devices (IUDs)
  • Others

Contraceptive Devices Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Contraceptive Devices Market, By End User:

  • Male
  • Female

Medical market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Europe & CIS
    • Germany
    • France
    • United Kingdom
    • Spain
    • Italy
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global Contraceptive Devices Market.

Available Customizations

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Impact of COVID-19 on Global Contraceptive Devices Market

5. Voice of Customer

6. Global Contraceptive Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, Intra Uterine Devices (IUDs), Others)
    • 6.2.2. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others)
    • 6.2.3. By End User (Male v/s Female)
    • 6.2.4. By Company (2021)
    • 6.2.5. By Region
  • 6.3. Market Map

7. North America Contraceptive Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Contraceptive Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Distribution Channel
        • 7.3.1.2.3. By End User
    • 7.3.2. Mexico Contraceptive Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Distribution Channel
        • 7.3.2.2.3. By End User
    • 7.3.3. Canada Contraceptive Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Distribution Channel
        • 7.3.3.2.3. By End User

8. Europe Contraceptive Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Contraceptive Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Distribution Channel
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Contraceptive Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Distribution Channel
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Contraceptive Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Distribution Channel
        • 8.3.3.2.3. By End User
    • 8.3.4. Italy Contraceptive Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Distribution Channel
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Contraceptive Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Distribution Channel
        • 8.3.5.2.3. By End User

9. Asia-Pacific Contraceptive Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Asia-Pacific: Country Analysis
    • 9.3.1. China Contraceptive Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Distribution Channel
        • 9.3.1.2.3. By End User
    • 9.3.2. India Contraceptive Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Distribution Channel
        • 9.3.2.2.3. By End User
    • 9.3.3. Japan Contraceptive Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Distribution Channel
        • 9.3.3.2.3. By End User
    • 9.3.4. South Korea Contraceptive Devices Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Product Type
        • 9.3.4.2.2. By Distribution Channel
        • 9.3.4.2.3. By End User
    • 9.3.5. Australia Contraceptive Devices Market Outlook
      • 9.3.5.1. Market Size & Forecast
        • 9.3.5.1.1. By Value
      • 9.3.5.2. Market Share & Forecast
        • 9.3.5.2.1. By Product Type
        • 9.3.5.2.2. By Distribution Channel
        • 9.3.5.2.3. By End User

10. South America Contraceptive Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Contraceptive Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Distribution Channel
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Contraceptive Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Distribution Channel
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Contraceptive Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Distribution Channel
        • 10.3.3.2.3. By End User

11. Middle East and Africa Contraceptive Devices Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Product Type
    • 11.2.2. By Distribution Channel
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Contraceptive Devices Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Product Type
        • 11.3.1.2.2. By Distribution Channel
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Contraceptive Devices Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Product Type
        • 11.3.2.2.2. By Distribution Channel
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Contraceptive Devices Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Product Type
        • 11.3.3.2.2. By Distribution Channel
        • 11.3.3.2.3. By End User
    • 11.3.4. Egypt Contraceptive Devices Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Product Type
        • 11.3.4.2.2. By Distribution Channel
        • 11.3.4.2.3. By End User
    • 11.3.5. Turkey Contraceptive Devices Market Outlook
      • 11.3.5.1. Market Size & Forecast
        • 11.3.5.1.1. By Value
      • 11.3.5.2. Market Share & Forecast
        • 11.3.5.2.1. By Product Type
        • 11.3.5.2.2. By Distribution Channel
        • 11.3.5.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Competitive Landscape

  • 14.1. Cooper Surgical, Inc.
  • 14.2. Pfizer, Inc
  • 14.3. Merck & Co Inc
  • 14.4. AbbVie, Inc
  • 14.5. Teva Pharmaceutical Industries Limited
  • 14.6. Ansell Ltd
  • 14.7. Bayer AG
  • 14.8. Mayer Laboratories Inc
  • 14.9. Church & Dwight Co Inc
  • 14.10. Reckitt Benckiser Group plc.

15. Strategic Recommendations